Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection
Status:
Unknown status
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of oral linezolid-rifampin combination
therapy (over 4 or 6 weeks) versus the standard of care in the treatment of Gram-positive
prosthetic hip joint infection with a one-stage surgical treatment.